Solution Structure of the Immunodominant Domain of Protective Antigen GNA1870 of Neisseria meningitidis*
暂无分享,去创建一个
R. Rappuoli | V. Masignani | L. Banci | M. Pizza | S. Savino | M. Scarselli | D. Veggi | F. Cantini | G. Romagnoli | E. Swennen
[1] R. Rappuoli,et al. The Region Comprising Amino Acids 100 to 255 of Neisseria meningitidis Lipoprotein GNA 1870 Elicits Bactericidal Antibodies , 2005, Infection and Immunity.
[2] Frances M. G. Pearl,et al. The CATH Domain Structure Database and related resources Gene3D and DHS provide comprehensive domain family information for genome analysis , 2004, Nucleic Acids Res..
[3] M. Comanducci,et al. Protective Activity of Monoclonal Antibodies to Genome-Derived Neisserial Antigen 1870, a Neisseria meningitidis Candidate Vaccine1 , 2004, The Journal of Immunology.
[4] Laurence Lins,et al. Transferrin-Binding Protein B of Neisseria meningitidis: Sequence-Based Identification of the Transferrin-Binding Site Confirmed by Site-Directed Mutagenesis , 2004, Journal of bacteriology.
[5] P. Güntert. Automated NMR structure calculation with CYANA. , 2004, Methods in molecular biology.
[6] Piet Gros,et al. Crystal Structure of Neisserial Surface Protein A (NspA), a Conserved Outer Membrane Protein with Vaccine Potential* , 2003, Journal of Biological Chemistry.
[7] Jeannette Adu-Bobie,et al. Vaccination against Neisseria meningitidis Using Three Variants of the Lipoprotein GNA1870 , 2003, The Journal of experimental medicine.
[8] S. Smith‐Gill,et al. Dissection of binding interactions in the complex between the anti-lysozyme antibody HyHEL-63 and its antigen. , 2003, Biochemistry.
[9] M. Achtman,et al. Crystal structure of the OpcA integral membrane adhesin from Neisseria meningitidis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[10] R. Mariuzza,et al. Molecular recognition in antibody-antigen complexes. , 2002, Advances in protein chemistry.
[11] K. Tanizawa,et al. Structure of a quinohemoprotein amine dehydrogenase with an uncommon redox cofactor and highly unusual crosslinking , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[12] L. Wyns,et al. Degenerate interfaces in antigen-antibody complexes. , 2001, Journal of molecular biology.
[13] T. Popović,et al. exl, an Exchangeable Genetic Island in Neisseria meningitidis , 2001, Infection and Immunity.
[14] K. Kano,et al. New pathway of amine oxidation respiratory chain of Paracoccus denitrificans IFO 12442. , 2001, European journal of biochemistry.
[15] Gottfried Otting,et al. Alignment of Biological Macromolecules in Novel Nonionic Liquid Crystalline Media for NMR Experiments , 2000 .
[16] A. Cripps,et al. Immunization with Recombinant Transferrin Binding Protein B Enhances Clearance of Nontypeable Haemophilus influenzae from the Rat Lung , 1999, Infection and Immunity.
[17] J. Tappero,et al. Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. , 1999, JAMA.
[18] A. Schryvers,et al. Identification of sequences in human transferrin that bind to the bacterial receptor protein, transferrin‐binding protein B , 1999, Molecular microbiology.
[19] A. Rosato,et al. Partial Orientation of Oxidized and Reduced Cytochrome b5 at High Magnetic Fields: Magnetic Susceptibility Anisotropy Contributions and Consequences for Protein Solution Structure Determination , 1998 .
[20] C Sander,et al. Dictionary of recurrent domains in protein structures , 1998, Proteins.
[21] M. Klein,et al. The Transferrin Binding Protein B of Moraxella catarrhalis Elicits Bactericidal Antibodies and Is a Potential Vaccine Antigen , 1998, Infection and Immunity.
[22] A. Bax,et al. Measurement of J and dipolar couplings from simplified two-dimensional NMR spectra. , 1998, Journal of magnetic resonance.
[23] B. Plikaytis,et al. Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland. , 1998, The Journal of infectious diseases.
[24] N. Cadieux,et al. Highly Conserved Neisseria meningitidis Surface Protein Confers Protection against Experimental Infection , 1997, The Journal of experimental medicine.
[25] J. Thornton,et al. AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR , 1996, Journal of biomolecular NMR.
[26] S. Gray-Owen,et al. Bacterial transferrin and lactoferrin receptors. , 1996, Trends in microbiology.
[27] D. Ala'aldeen,et al. The meningococcal transferrin-binding proteins 1 and 2 are both surface exposed and generate bactericidal antibodies capable of killing homologous and heterologous strains. , 1996, Vaccine.
[28] E. Rosenqvist,et al. Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine , 1995, Infection and immunity.
[29] Peter A. Kollman,et al. AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules , 1995 .
[30] P. Dumas,et al. Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines , 1995, Infection and immunity.
[31] B. Sykes,et al. Quantification of the calcium‐induced secondary structural changes in the regulatory domain of troponin‐C , 1994, Protein science : a publication of the Protein Society.
[32] T. Pawson,et al. Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. , 1994, Biochemistry.
[33] S. Grzesiek,et al. Measurement of homo- and heteronuclear J couplings from quantitative J correlation. , 1994, Methods in enzymology.
[34] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[35] S. Grzesiek,et al. The Importance of Not Saturating H2o in Protein NMR : application to Sensitivity Enhancement and Noe Measurements , 1993 .
[36] C. Sacchi,et al. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil , 1992, The Lancet.
[37] Jeffrey W. Peng,et al. Mapping of Spectral Density Functions Using Heteronuclear NMR Relaxation Measurements , 1992 .
[38] A. Halstensen,et al. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway , 1991, The Lancet.
[39] C. Frasch. Vaccines for prevention of meningococcal disease , 1989, Clinical Microbiology Reviews.
[40] M. Artenstein,et al. HUMAN IMMUNITY TO THE MENINGOCOCCUS : III. PREPARATION AND IMMUNOCHEMICAL PROPERTIES OF THE GROUP A, GROUP B, AND GROUP C MENINGOCOCCAL POLYSACCHARIDES , 1969 .
[41] S. Branham,et al. Serological relationships among meningococci. , 1953, Bacteriological reviews.